Therapeutics: Interleukin-33 (IL-33, NF-HEV)

Endocrine/metabolic disease

INDICATION: Obesity

Studies in mice and patients suggest stimulating IL-33 signaling

Read the full 111 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE